Coley's toxins in perspective
- 1 May 1992
- journal article
- other
- Published by Springer Nature in Nature
- Vol. 357 (6373) , 11-12
- https://doi.org/10.1038/357011a0
Abstract
Despite initial hopes, the efficacy of tumour necrosis factor in treating cancer patients has been disappointing. But a more careful selection of patients, and more appropriate treatment, might be fruitful.Keywords
This publication has 6 references indexed in Scilit:
- Clinical Studies of Tumor Necrosis Factor in the USAPublished by S. Karger AG ,2015
- A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo.Journal of Clinical Oncology, 1989
- Effect of the mixed bacterial vaccine on the immune response of patients with non-small cell lung cancer and refractory malignanciesCancer, 1988
- The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity.The Journal of Experimental Medicine, 1978
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975
- Remarks upon the Effects Observed in the Use of Mixed Toxins (Coley) in Certain Cases of SarcomaNew England Journal of Medicine, 1914